We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 The Lung Health Study

Nicholas R. Anthonisen, MD; John E. Connett, PhD; James P. Kiley, PhD; Murray D. Altose, MD; William C. Bailey, MD; A. Sonia Buist, MD; William A. Conway Jr, MD; Paul L. Enright, MD; Richard E. Kanner, MD; Peggy O'Hara, PhD; Gregory R. Owens, MD; Paul D. Scanlon, MD; Donald P. Tashkin, MD; Robert A. Wise, MD; M. D. Altose, MD; A. F. Connors, MD; S. Redline, MD; C. Deitz, PhD; R. F. Rakos, PhD; W. A. Conway Jr, MD; A. DeHorn, PhD; J. C. Ward, MD; C. S. Hoppe-Ryan, CSW; R. L. Jentons, MA; J. A. Reddick, RN; C. Sawicki, RN, MPH; R. A. Wise, MD; S. Permutt, MD; C. S. Rand, PhD; P. D. Scanlon, MD; L. J. Davis, PhD; R. D. Hurt, MD; R. D. Miller, MD; D. E. Williams, MD; G. M. Caron; G. G. Lauger, MS; S. M. Toogood; A. S. Buist, MD; W. M. Bjornson, MPH; L. R. Johnson, PhD; W. C. Bailey, MD; C. M. Brooks, EdD; J. J. Dolce, PhD; D. M. Higgins; M. A. Johnson; C. D. Lorish, PhD; B. A. Martin; D. P. Tashkin, MD; A. H. Coulson; H. Gong, MD; P. I. Harber, MD; V. C. Li, PhD, MPH; M. Roth, MD; M. A. Nides, PhD; M. S. Simmons; I. Zuniga; N. R. Anthonisen, MD; J. Manfreda, MD; R. P. Murray, PhD; S. C. Rempel-Rossum; J. M. Stoyko; J. E. Connett, PhD; M. O. Kjelsberg, PhD; M. K. Cowles, MS; D. A. Durkin; P. L. Enright, MD; K. J. Kurnow, MS; W. W. Lee, MS; P. G. Lindgren, MS; S. J. Mongin, MS; P. O'Hara, PhD; H. T. Voelker; L. A. Waller, PhD; G. R. Owens, MD; R. M. Rogers, MD; J. J. Johnston, PhD; F. P. Pope, MSW; F. M. Vitale, MA; R. E. Kanner, MD; M. A. Rigdon, PhD; K. C. Benton; P. M. Grant; M. Becklake, MD; B. Burrows, MD; P. Cleary, PhD; P. Kimbel, MD; L. Nett, RN, RRT; J. K. Ockene, PhD; R. M. Senior, MD; G. L. Snider, MD; W. Spitzer, MD; O. D. Williams, PhD; S. S. Hurd, PhD; J. P. Kiley, PhD; M. C. Wu, PhD; S. M. Ayres, MD; R. E. Hyatt, MD; B. A. Mason, MD
JAMA. 1994;272(19):1497-1505. doi:10.1001/jama.1994.03520190043033.
Text Size: A A A
Published online


Objective.  —To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 second (FEV1) in smokers aged 35 to 60 years who have mild obstructive pulmonary disease.

Design.  —Randomized clinical trial. Participants randomized with equal probability to one of the following groups: (1) smoking intervention plus bronchodilator, (2) smoking intervention plus placebo, or (3) no intervention.

Setting.  —Ten clinical centers in the United States and Canada.

Participants.  —A total of 5887 male and female smokers, aged 35 to 60 years, with spirometric signs of early chronic obstructive pulmonary disease.

Interventions.  —Smoking intervention: intensive 12-session smoking cessation program combining behavior modification and use of nicotine gum, with continuing 5-year maintenance program to minimize relapse. Bronchodilator: ipratropium bromide prescribed three times daily (two puffs per time) from a metered-dose inhaler.

Main Outcome Measures.  —Rate of change and cumulative change in FEV1 over a 5-year period.

Results.  —Participants in the two smoking intervention groups showed significantly smaller declines in FEV1 than did those in the control group. Most of this difference occurred during the first year following entry into the study and was attributable to smoking cessation, with those who achieved sustained smoking cessation experiencing the largest benefit. The small noncumulative benefit associated with use of the active bronchodilator vanished after the bronchodilator was discontinued at the end of the study.

Conclusions.  —An aggressive smoking intervention program significantly reduces the age-related decline in FEV1 in middle-aged smokers with mild airways obstruction. Use of an inhaled anticholinergic bronchodilator results in a relatively small improvement in FEV1 that appears to be reversed after the drug is discontinued. Use of the bronchodilator did not influence the long-term decline of FEV1.(JAMA. 1994;272:1497-1505)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.